title: Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Piccini
authors.forename: David F
authors.initials: DF
authors.lastname: Kong
mesh_terms: D000638:Amiodarone / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D000077764:Dronedarone; D019317:Evidence-Based Medicine; D005424:Flecainide / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D011405:Propafenone / Q000009:adverse effects / Q000627:therapeutic use; D013015:Sotalol / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D011405:Propafenone; D013015:Sotalol; D000077764:Dronedarone; D005424:Flecainide; D000638:Amiodarone